1996
DOI: 10.1097/00000539-199605000-00035
|View full text |Cite
|
Sign up to set email alerts
|

Epidural Hematoma Associated with Enoxaparin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…Hynson et al described a case where a patient developed a spinal haematoma after epidural anaesthesia in association with prophylactic LMWH and no other risk factor. 8 In contrast to our patient, this patient received a two times per day dose as common in the USA. 8 A possibility to monitor the activity of LMWH is to measure the anti-Xa activity in the laboratory testing.…”
Section: Discussionmentioning
confidence: 71%
“…Hynson et al described a case where a patient developed a spinal haematoma after epidural anaesthesia in association with prophylactic LMWH and no other risk factor. 8 In contrast to our patient, this patient received a two times per day dose as common in the USA. 8 A possibility to monitor the activity of LMWH is to measure the anti-Xa activity in the laboratory testing.…”
Section: Discussionmentioning
confidence: 71%
“…In addition, the type of anaesthesia may be affected by anticoagulation. Bleeding and neurological dysfunction may occur during the insertion or removal of a spinal or epidural catheter in an anticoagulated patient [2527]. Warfarin therapy is a contraindication for regional anaesthesia, such as spinal and epidural [12].…”
Section: Discussionmentioning
confidence: 99%
“…LMWH have a dose-dependent bleeding potential [12,13]. It is interesting to note that in North America the approved dose of enoxaparin is 30 mg twice daily while in Europe a 40 mg single daily dose is used [4,5,9,14].…”
Section: Discussionmentioning
confidence: 99%
“…This case used European practice guidelines for the use of LMWH. The use of low dose LMWH does not usually require monitoring of the anticoagulant effect because of the predictability of its effect [12,13]. However, the use of high dose LMWH in elderly patients with multisystem disease probably requires laboratory monitoring [12].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation